Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 26% ± 8% | |
| GABAergic neuron | 5 studies | 35% ± 16% | |
| glutamatergic neuron | 4 studies | 52% ± 17% | |
| endothelial cell of lymphatic vessel | 4 studies | 25% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 4% | |
| interneuron | 3 studies | 40% ± 21% | |
| astrocyte | 3 studies | 25% ± 7% | |
| oligodendrocyte | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 33% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 566.63 | 2641 / 2642 | 100% | 10.79 | 705 / 705 |
| prostate | 100% | 474.94 | 245 / 245 | 100% | 8.32 | 501 / 502 |
| breast | 100% | 460.52 | 459 / 459 | 99% | 10.39 | 1111 / 1118 |
| thymus | 100% | 506.41 | 653 / 653 | 99% | 7.61 | 598 / 605 |
| adrenal gland | 100% | 491.43 | 258 / 258 | 97% | 6.51 | 223 / 230 |
| ovary | 100% | 572.09 | 180 / 180 | 97% | 6.80 | 416 / 430 |
| pancreas | 99% | 209.64 | 325 / 328 | 96% | 4.76 | 170 / 178 |
| bladder | 100% | 474.57 | 21 / 21 | 93% | 5.36 | 471 / 504 |
| kidney | 100% | 322.12 | 89 / 89 | 92% | 5.36 | 830 / 901 |
| uterus | 100% | 536.09 | 170 / 170 | 90% | 6.39 | 413 / 459 |
| lung | 99% | 324.28 | 570 / 578 | 91% | 5.63 | 1047 / 1155 |
| intestine | 100% | 428.86 | 966 / 966 | 84% | 3.90 | 442 / 527 |
| skin | 100% | 401.90 | 1806 / 1809 | 83% | 4.99 | 391 / 472 |
| stomach | 100% | 317.02 | 358 / 359 | 81% | 3.77 | 231 / 286 |
| liver | 99% | 207.97 | 223 / 226 | 71% | 2.78 | 290 / 406 |
| esophagus | 100% | 421.43 | 1444 / 1445 | 62% | 2.82 | 114 / 183 |
| blood vessel | 100% | 445.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 496.41 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.89 | 1 / 1 |
| adipose | 100% | 416.68 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 356.40 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 256.30 | 835 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 4.91 | 28 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 4.23 | 37 / 45 |
| eye | 0% | 0 | 0 / 0 | 69% | 2.82 | 55 / 80 |
| peripheral blood | 52% | 153.00 | 483 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF420 |
| Protein name | Zinc finger protein 420 |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | K7EJW2 K7EQC9 ENST00000589245.5 Q8TAQ5 K7ELF6 ENST00000587029.5 ENST00000585862.1 K7ESJ1 ENST00000587082.5 ENST00000337995.4 [Q8TAQ5-1] K7EPG0 ENST00000304239.11 [Q8TAQ5-2] ENST00000589461.5 ENST00000590332.1 K7ERS3 |
